Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gold Nanoparticles Treatment Reverses Brain Damage in Alzheimer’s Disease Model
Natália dos Santos Tramontin, Sabrina da Silva, Rychard Arruda, et al.
Molecular Neurobiology (2019) Vol. 57, Iss. 2, pp. 926-936
Closed Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

A review on advances of treatment modalities for Alzheimer's disease
Ewen Se Thoe, Ayesha Fauzi, Yin-Quan Tang, et al.
Life Sciences (2021) Vol. 276, pp. 119129-119129
Closed Access | Times Cited: 149
Gold Nanoparticles: Biosynthesis and Potential of Biomedical Application
Е. О. Михайлова
Journal of Functional Biomaterials (2021) Vol. 12, Iss. 4, pp. 70-70
Open Access | Times Cited: 126
Targeting autophagy, oxidative stress, and ER stress for neurodegenerative disease treatment
Yasaman Esmaeili, Zahra Yarjanli, Fatemeh Pakniya, et al.
Journal of Controlled Release (2022) Vol. 345, pp. 147-175
Closed Access | Times Cited: 118
Current Overview of Metal Nanoparticles’ Synthesis, Characterization, and Biomedical Applications, with a Focus on Silver and Gold Nanoparticles
Ana Flavia Burlec, Andreia Corciovă, Monica Boev, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1410-1410
Open Access | Times Cited: 87
Gold nanostructures: synthesis, properties, and neurological applications
Iman Zare, Mohammad Tavakkoli Yaraki, G. Speranza, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 7, pp. 2601-2680
Closed Access | Times Cited: 81
Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection
Ming‐Chang Chiang, Yuping Yang, Christopher J.B. Nicol, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2360-2360
Open Access | Times Cited: 24
Mitochondria‐targeted nanoparticles in treatment of neurodegenerative diseases
Yue Zhang, Han Yang, Daohe Wei, et al.
Exploration (2021) Vol. 1, Iss. 3
Open Access | Times Cited: 96
Nanoparticles: A Hope for the Treatment of Inflammation in CNS
Feng‐Dan Zhu, Yu-Jiao Hu, Lu Yu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 66
Recent Advances in the Treatment of Alzheimer’s Disease Using Nanoparticle-Based Drug Delivery Systems
Prashant Poudel, Soyeun Park
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 835-835
Open Access | Times Cited: 62
Nanomedicine: A Promising Way to Manage Alzheimer’s Disease
Nazeer Hussain Khan, Maria Mir, Ebenezeri Erasto Ngowi, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 60
The roles of gold nanoparticles in the detection of amyloid-β peptide for Alzheimer's disease
Jiuhong Zhao, Na Xu, Xiaotong Yang, et al.
Colloids and Interface Science Communications (2022) Vol. 46, pp. 100579-100579
Open Access | Times Cited: 54
Nano‐Brake Halts Mitochondrial Dysfunction Cascade to Alleviate Neuropathology and Rescue Alzheimer's Cognitive Deficits
Qian Zhang, Qingxiang Song, Renhe Yu, et al.
Advanced Science (2023) Vol. 10, Iss. 7
Open Access | Times Cited: 40
Anti-inflammatory role of gold nanoparticles in the prevention and treatment of Alzheimer's disease
Munire Aili, Kebing Zhou, Jun Zhan, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8605-8621
Open Access | Times Cited: 26
Multifaceted nanoparticles: emerging mechanisms and therapies in neurodegenerative diseases
Miriam Mistretta, Andrea Farini, Yvan Torrente, et al.
Brain (2023) Vol. 146, Iss. 6, pp. 2227-2240
Open Access | Times Cited: 25
Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective
Dur e Nayab, Fakhar ud Din, Hussain Ali, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Nanochemistry of gold: from surface engineering to dental healthcare applications
Shuang Zhang, Na Kong, Zezheng Wang, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 8, pp. 3656-3686
Closed Access | Times Cited: 12
Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease
Antea Kršek, Lara Batičić
Future Pharmacology (2024) Vol. 4, Iss. 2, pp. 352-379
Open Access | Times Cited: 9
Design, Current States, and Challenges of Nanomaterials in Anti-Neuroinflammation: A Perspective on Alzheimer’s Disease
Xinyang Hong, Tongkai Chen, Yunyun Liu, et al.
Ageing Research Reviews (2025), pp. 102669-102669
Closed Access | Times Cited: 1
The blood–brain barriers: novel nanocarriers for central nervous system diseases
Jiajun Liu, Ting Wang, Jianwei Dong, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders
Ebenezeri Erasto Ngowi, Yizhen Wang, Lei Qian, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 48
Nanomaterials alleviating redox stress in neurological diseases: mechanisms and applications
Yan‐Ping Jiang, Yiyuan Kang, Jia Liu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 36
Advances on Therapeutic Strategies for Alzheimer’s Disease: From Medicinal Plant to Nanotechnology
Nasser A. Hassan, Asma K. Alshamari, Allam A. Hassan, et al.
Molecules (2022) Vol. 27, Iss. 15, pp. 4839-4839
Open Access | Times Cited: 32
mTOR-Mediated Immunometabolic Reprogramming Nanomodulators Enable Sensitive Switching of Energy Deprivation-Induced Microglial Polarization for Alzheimer’s Disease Management
Fan Yang, Dongju Zhao, Meng Cheng, et al.
ACS Nano (2023) Vol. 17, Iss. 16, pp. 15724-15741
Closed Access | Times Cited: 21
Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
Cyrus Jalili, Amir Kiani, Mohammadreza Gholami, et al.
IET Nanobiotechnology (2023) Vol. 17, Iss. 3, pp. 154-170
Open Access | Times Cited: 20
Advancements in the Application of Nanomedicine in Alzheimer’s Disease: A Therapeutic Perspective
Nidhi Puranik, Dhananjay Yadav, Minseok Song
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14044-14044
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top